Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Not Applicable
Recruiting
- Conditions
- Type 1 AllergyAnaphylaxis
- Interventions
- Drug: Epinephrine Auto-Injector 0.3 mg/0.3 mLDrug: Epinephrine 0.3 mg intramuscular manual injection via a syringe and needleDrug: IN-001 9.06 mg Sublingual SprayDrug: IN-001 13.59 mg Sublingual Spray
- First Posted Date
- 2025-10-07
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- Insignis Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT07210320
- Locations
- 🇺🇸
Washington University in St. Louis School of Medicine, St Louis, Missouri, United States
News
No news found